Myelodysplastic Syndromes |
1 James P. Wilmot Cancer Center, University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY
2 Weill Medical College of Cornell University, Department of Pathology and Laboratory Medicine, New York, NY, USA
Correspondence: John M. Bennett, M.D., James P. Wilmot Cancer Center, University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, 601 Elmwood Avenue, Box 626, Rochester, NY 14642 USA., E-mail:John_Bennett{at}urmc.rochester.edu
Members of the French-American-British Cooperative Leukemia Working Group met to review cases of aplastic anemia, hypocellular myelodysplastic syndrome and hypocellular acute myeloid leukemia. Criteria were proposed and modified following three workshops. Additional input was obtained from another hematopathologist with a special interest in bone marrow histology and immunohistochemistry. Guidelines were recommended based on the workshop results as well as additional studies including selective immunohistochemistry, flow cytometry and cytogenetics.
Key words: hypocellular myelodysplasia, hypocellular myeloid leukemia, abnormal localization of immature precursors, aplastic anemia.
This article has been cited by other articles:
![]() |
M. Cazzola Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome Haematologica, August 1, 2009; 94(8): 1041 - 1043. [Full Text] [PDF] |
||||